What's breaking now, across thousands of outlets.
GSK’s Jideytro posted an impressive response rate of 94% in a first-line treatment for ROS1-positive non-small cell lung cancer patients, according to results shared at the World Conference on Lung Cancer over the weekend. GSK ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Inflammation associated with asthma and other allergic airway diseases can be significantly worsened by exposure to both house dust mite allergens and crystalline silica, according to a new study…
The New York City Health Department on September 13 ordered 10 cooling towers in the South Bronx to be cleaned and disinfected as the city continued its investigation into the latest community cluster…
"Why do people speak while they are sleeping?—Mubina, age 15, Uzbekistan"
Lured by promises of payment and a desire to help other families, surrogates discover they have few, if any, meaningful protections.
(MedPage Today) -- Patients with newly diagnosed idiopathic inflammatory myopathies (IIMs) such as dermatomyositis improved more when they received intravenous immunoglobulin (IVIG) alongside…
(MedPage Today) -- When a child presented to the emergency department with a brown, lace-like rash on his abdomen, it took a few weeks before physicians pinpointed the likely source.
